Psoriatic Arthritis
Expert Perspective
Uveitis Associated with Psoriatic Arthritis: Characteristics, Approaches, and Treatment
News
Comorbidities, CV risk factors common in early PsA
Data illustrated increased odds of metabolic burden in adults newly diagnosed with psoriatic arthritis.
News
PsA biomarkers move researchers closer to predictive test
Researchers have identified 15 genes that may indicate which patients with psoriasis will develop psoriatic arthritis.
Expert Perspective
A Review of Evidence and Safety for First-Line JAKi Use in PsA
News
EULAR PsA recommendations update emphasizes safety, nonmusculoskeletal manifestations
The update builds on 2019 recommendations and incorporates safety concerns about JAK inhibitors, advises on differential drug efficacy across...
Conference Coverage
MACE, VTE rates compared between TNF and JAK inhibitors for AxSpA and PsA
Patients with axial spondyloarthritis and psoriatic arthritis who used JAK inhibitors did not have higher risk of myocardial infarction or stroke...
Expert Perspective
The Current and Future Role of JAK Inhibitors for Psoriatic Arthritis
News
Psoriatic arthritis treatment for women falls short, study suggests
Women with psoriatic arthritis who were treated with ustekinumab or a tumor necrosis factor inhibitor had lower response rates and persistence at...
News
Isolated nail psoriasis may bring arthritis into play
The review of 20 years of cases show delayed diagnosis, delineate clinical features, and suggest a relationship with PsA.
News
What’s holding back physicians from prescribing biosimilars? Four specialties weigh in
Physicians surveyed from four different specialties reported that they were generally comfortable prescribing biosimilars, but greater discounts...